The National Pharmaceutical Council (NPC) is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation.
Founded in 1953 and supported by the nation’s major research-based biopharmaceutical companies, NPC focuses on research development, information dissemination, education and communication of the critical issues of evidence, innovation and the value of medicines for patients. The issues we select for examination and the researchers and academics we partner with position NPC as a uniquely credible and trusted voice in the biopharmaceutical research and health policy communities. Much of our research is published in peer-reviewed journals.
NPC is working to:
- Ensure that sound evidence is recognized by independent experts, considered appropriately by private and public payers, reflected adequately in benefit designs, and incorporated into clinical practice
- Demonstrate and promote the contribution of innovative medicines to optimizing health and wellness for patients and the entire health care system through scientific analyses and fact-based communications
- Maintain a focus on the issues related to advancing the science and research aspects of the biopharmaceutical industry and preserving and improving an environment supportive of innovation.
Our Board of Directors consists of a representative from each member company. The annual dues paid by our members make up NPC’s core budget, which funds research-based projects, ongoing educational activities and our day-to-day operations. NPC does not engage in lobbying activities.